Latest market price
18.21
-0.08-0.44%
OverviewShort InterestFilings
IMNMQT25Immunome, Inc.·NASDAQ
18.21-0.44%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 2026SC 13GBeneficial ownership statement (passive)
Oct 05, 20268-KCurrent report
Sep 15, 20264Statement of changes in beneficial ownership
Sep 11, 2026144Notice of proposed sale of restricted securities
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026144Notice of proposed sale of restricted securities
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 20268-KCurrent report
Aug 11, 2026S-8Registration of employee benefit securities
Aug 11, 202610-QQuarterly report
Aug 10, 20264Statement of changes in beneficial ownership
Aug 06, 20264Statement of changes in beneficial ownership
Aug 06, 2026144Notice of proposed sale of restricted securities
Aug 04, 2026144Notice of proposed sale of restricted securities
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 09, 20264Statement of changes in beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
#1 / 25 of 349
Page
▼
/ 14